NO20051602L - Assosiering av H2 haplotypen av P2Y12 reseptoren med en oket risiko for trombose og perifer arteriell sykdom - Google Patents

Assosiering av H2 haplotypen av P2Y12 reseptoren med en oket risiko for trombose og perifer arteriell sykdom

Info

Publication number
NO20051602L
NO20051602L NO20051602A NO20051602A NO20051602L NO 20051602 L NO20051602 L NO 20051602L NO 20051602 A NO20051602 A NO 20051602A NO 20051602 A NO20051602 A NO 20051602A NO 20051602 L NO20051602 L NO 20051602L
Authority
NO
Norway
Prior art keywords
thrombosis
haplotype
receptor
association
increased risk
Prior art date
Application number
NO20051602A
Other languages
English (en)
Norwegian (no)
Inventor
Sophie Gandrille
Pascale Gaussem
Pierre Fontana
Annabelle Dupont
Martine Aiach
Jean-Luc Reny
Original Assignee
Univ Paris Descartes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20020292543 external-priority patent/EP1411130A1/en
Application filed by Univ Paris Descartes filed Critical Univ Paris Descartes
Publication of NO20051602L publication Critical patent/NO20051602L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20051602A 2002-10-15 2005-03-30 Assosiering av H2 haplotypen av P2Y12 reseptoren med en oket risiko for trombose og perifer arteriell sykdom NO20051602L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20020292543 EP1411130A1 (en) 2002-10-15 2002-10-15 Association of the H2 haplotype of the P2Y12 receptor with an increased risk for thrombosis and peripheral arterial disease
EP20030291129 EP1411134A1 (en) 2002-10-15 2003-05-14 Association of the H2 haplotype of the P2Y12 receptor with an increased risk for thrombosis and peripheral arterial disease
PCT/IB2003/004513 WO2004035826A1 (en) 2002-10-15 2003-10-14 Association of the h2 haplotype of the p2y12 receptor with an increased risk for thrombosis and peripheral arterial disease

Publications (1)

Publication Number Publication Date
NO20051602L true NO20051602L (no) 2005-05-13

Family

ID=32044347

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051602A NO20051602L (no) 2002-10-15 2005-03-30 Assosiering av H2 haplotypen av P2Y12 reseptoren med en oket risiko for trombose og perifer arteriell sykdom

Country Status (8)

Country Link
US (1) US20060177821A1 (ko)
EP (2) EP1411134A1 (ko)
JP (1) JP2006502746A (ko)
KR (1) KR20050053761A (ko)
AU (1) AU2003267750A1 (ko)
CA (1) CA2502454A1 (ko)
NO (1) NO20051602L (ko)
WO (1) WO2004035826A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090004673A1 (en) * 2006-01-31 2009-01-01 Mitsubishi Kagaku Iatron, Inc. Method for Determining Condition of Disseminated Intravascular Coagulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846727A (en) * 1996-06-06 1998-12-08 Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College Microsystem for rapid DNA sequencing
AU2288601A (en) * 1999-12-23 2001-07-03 Millennium Pharmaceuticals, Inc. P2Y12 receptor
WO2002036631A1 (fr) * 2000-11-01 2002-05-10 Yamanouchi Pharmaceutical Co., Ltd. Procede de criblage d'anti-plaquettes

Also Published As

Publication number Publication date
CA2502454A1 (en) 2004-04-29
EP1551996A1 (en) 2005-07-13
JP2006502746A (ja) 2006-01-26
KR20050053761A (ko) 2005-06-08
US20060177821A1 (en) 2006-08-10
AU2003267750A1 (en) 2004-05-04
EP1411134A1 (en) 2004-04-21
WO2004035826A1 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
BRPI0411200A (pt) método de tratamento de cáncer, métodos de tratamento de paciente humano, artigo industrializado e kit de tratamento de cáncer
DK1835924T3 (da) Behandling af parkinsons sygdom og beslægtede sygdomme under anvendelse af postpartum opnåede celler
WO1999067417A3 (en) Fitness assay and associated methods
FR2838631B1 (fr) Procede de realisation d'une prothese de valve cardiaque aortique ou mitrale et prothese de valve cardiaque aortique ou mitrale ainsi obtenue
ATE353657T1 (de) Verwendung von immunerregenden oligonukleotiden zur vorbeugung oder behandlung von asthma
CY1108730T1 (el) Θεραπεια ασθενειας hundington με epa
DK1351707T3 (da) Fremgangsmåder til behandling af autoimmunsygdomme hos et individ og in vitro-diagnostiske analyser
DK1348029T3 (da) Materialer og fremgangsmåder involveret i proteinaggregering i neurodegenerative sygdomme
NO20024224D0 (no) Et intelligent og tidsvarierende "out of home" informasjons- eller markedsföringssystem
DK1428023T3 (da) Fremgangsmåde til forudsigelse af lægemiddelsensitivitet hos patienter der lider af en inflammatorisk sygdom
WO2004068110A3 (en) Methods of predicting mortality risk by determining telomere length
DE60223176D1 (de) Metallkomplexverbindungen
AU2003302732A1 (en) Method for identifying risk of breast cancer and treatments thereof
NO20002697D0 (no) Diagnostisk metode, diagnostisk reagens og terapeutisk preparat for sykdommer forÕrsaket av variasjon i LKB1-gen
NO20051602L (no) Assosiering av H2 haplotypen av P2Y12 reseptoren med en oket risiko for trombose og perifer arteriell sykdom
DK1276752T3 (da) Fremgangsmåde til vurdering af risikoen for, at en person udvikler vaskulære komplikationer
ITMI20032172A1 (it) Procedimento atto alla correzione dell'arricchimento di
DE50303798D1 (de) Vorrichtung, um in einem Zielgebiet eines menschlichen oder tierischen Körpers einen künstlichen isolierten Kreislauf zu etablieren
BRPI0512709A (pt) métodos para prognóstico da resposta terapêutica a agentes atuando no receptor do hormÈnio do crescimento
EP1684807A4 (en) METHOD FOR IDENTIFYING RESPONDER TO TREATMENT MTI INSULIN SENSITIZER
PL330014A1 (en) Application of genetic modification of the gene of human protein g subjunit beta3 in diagnosing diseases
AU2003276727A8 (en) Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes
CA2523297A1 (en) Inhibitor screening method and atopic dermatitis-like symptom inducing method which utilizes induction of production of interleukin 18 by keratinocyte, and utilization of same
RU2763641C1 (ru) Способ оценки прогнозируемого сдвига скорректированной средней фазы сна по Мюнхенскому тесту Munich Chrono-Type Questionnaire при изменении времени дневной световой экспозиции у лиц со свободным графиком работ
WO2002086508A3 (en) Elisa kit for the determination of cyp2c19 metabolic phenotypes and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application